Assignee
SHANGHAI HEP PHARMACEUTICAL CO LTD
CN·2 granted patents·4 pending applications·1 citations·filing 2014–2023
Top patents by PatentIndex Score
6 records- 0169US11633454B2Compositions and methods for treating metabolic diseasesSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 25, 2023·1 cites·19 claims
- 0264US2023414706A1Compositions and methods for treating metabolic diseasesSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0355US2025161335A1Drug and Method for Nucleoside (Acid) Drug Therapy of Limiting Chronic Hepatitis BSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0448US10603352B2Formulations of hepalatideSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 31, 2020·0 cites·18 claims
- 0542US2020316166A1Drug and Method for Treating Liver Diseases Related to Hepatitis B Viruses in Full-Dose ConditionSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 0642US2020338158A1Therapeutic Drug for Non-Alcoholic Fatty Liver DiseaseSHANGHAI HEP PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI HEP PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →